GlassScriptPhysician profile
Tara R Ennis
NPI 1700961141
$15,374.39
in general payments reported to CMS, 2019-2025
9 companies · $37.01 in 2025
The $37.01 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $39.83 · 2021: $28.76 · 2022: $1,961 · 2023: $2,439 · 2024: $17.40 · 2025: $37.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,248 · Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,247.51 |
| Food and Beverage | $246.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,573.09 | 2019-2023 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $909.45 | 2023 | Conduit |
| Nexxt Spine LLC | $735.50 | 2023 | Nexxt Alif |
| Ethicon US, LLC | $37.01 | 2025 | Vistaseal, Dermabond |
| Allergan, INC. | $36.01 | 2019-2020 | |
| Kci USA, INC. | $28.76 | 2021 | |
| Davol INC. | $25.05 | 2020 | |
| Solventum Corporation | $17.40 | 2024 | Prevena |
| Merck Sharp & Dohme LLC | $12.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Ennis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.